<DOC>
	<DOCNO>NCT00657683</DOCNO>
	<brief_summary>The goal propose study evaluate safety , tolerability immunogenicity GBS vaccine . Previous study suggest immune response GBS protect human infection .</brief_summary>
	<brief_title>A Phase I , Randomized , Single-blind , Controlled , Single Center Study Evaluate Safety Immunogenicity Dose Range Monovalent Glycoconjugate Antigen Vaccine Group B Streptococcus Healthy Women 18-40 Years Age</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>healthy female 18 40 year age ; provide write informed consent nature study explain ; available visit schedule study ( i.e . plan leave area end study period ) ; good health determine : medical history , physical assessment , clinical judgment investigator unwilling unable give write informed consent participate study ; pregnant ( serum pregnancy test ) unwilling use acceptable birth control screen least 3 month final immunization nursing ( breastfeed ) mother</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>GBS</keyword>
	<keyword>GBS prevention</keyword>
</DOC>